In a model of non-ischemic HF in dogs (tachycardiomyopathy induced by pacemakers), IV infusion of GLP-1 increases left ventricular (LV) contractility (LV dP/dt increased by 98%, stroke volume by 102%, and cardiac output by 57%) and decreases LV end-diastolic pressure, heart rate, and systemic vascular resistance
The Chronos Weight Coaching & Nutrition Program is physician-developed and patient-specific
(21:27): So what if neurons are actually also an overlooked mechanism here, and both of these neuronal populations have the GLP-1 receptor and are accessible from the periphery, even though the child super paper in Nature doesn't mention that, but they do have the GLP-1 receptor
Yes, they are commonly used on the stomach, as well as the abdomen, arms, thighs, and chin
Call: (405) 285-4762 [Schedule Your MOTS-C Consultation] External Resources MOTS-C Research PubMed AMPK and Metabolic Health NIH Mitochondrial Health and Aging Harvard Medical School Understanding Insulin Resistance American Diabetes Association MOTS-C peptide therapy should only be administered under the supervision of a qualified healthcare provider